Intercept Pharmaceuticals Inc - Company Profile

Powered by

All the data and insights you need on Intercept Pharmaceuticals Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Intercept Pharmaceuticals Inc Strategy Report

  • Understand Intercept Pharmaceuticals Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Intercept Pharmaceuticals Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Intercept Pharmaceuticals Inc (Intercept), a subsidiary of Alfasigma SpA, is a biopharmaceutical company that researches, develops, and commercializes treatments for non-viral, progressive liver diseases. It develops products using proprietary bile acid chemistry. The company’s lead product candidate, obeticholic acid (OCA), is a bile acid analog and first-in-class agonist of the farnesoid X receptor. The company is advancing OCA for the treatment of primary biliary cholangitis (PBC) and other liver diseases. The company harnesses its proprietary bile acid chemistry to develop innovative drugs. It is also advancing INT-787, an FXR agonist for the treatment of severe alcohol-associated hepatitis and obeticholic acid (OCA) and bezafibrate for the potential treatment of individuals with PBC. Intercept is headquartered in Morristown, New Jersey, the US.

Gain a 360-degree view of Intercept Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Intercept Pharmaceuticals Inc and make more informed decisions for your business Find out more
Headquarters United States of America

Address 305 Madison Avenue, Morristown, New Jersey, 07960


Telephone 1 646 7471000

No of Employees 341

Industry Pharmaceuticals and Healthcare

Revenue (2022) $285.7M

   

   

Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Intercept Pharmaceuticals Inc premium industry data and analytics

60+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

50+

Clinical Trials

Determine Intercept Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

50+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Intercept Pharmaceuticals Inc’s relevant decision makers and contact details.

30+

Catalyst Calendar

Proactively evaluate Intercept Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

5

Pipeline Drugs

Identify which of Intercept Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

Sales & Consensus Forecasts

Understand the current and future drug revenue for Intercept Pharmaceuticals Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Marketed Drugs

Understand Intercept Pharmaceuticals Inc’s commercialized product portfolio to stay one step ahead of the market.

Products and Services

Products
-
Marketed
Ocaliva (Obeticholic Acid): Primary Biliary Cholangitis (PBC)
XYZ
XYZ
XYZ
Understand Intercept Pharmaceuticals Inc portfolio and identify potential areas for collaboration Understand Intercept Pharmaceuticals Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Acquisitions/Mergers/Takeovers In November, the company got acquired by Alfasigma S.p.A.
2023 Regulatory Approval In May, the company announced that the U.S. Food and Drug Administration granted orphan drug designation for the fixed-dose combination of obeticholic acid (OCA) and bezafibrate for the potential treatment of individuals with primary biliary cholangitis (PBC).
2023 Others In March, the company announced FDA Advisory Committee meeting date for obeticholic acid as a treatment for pre-cirrhotic liver fibrosis to be held virtually.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Intercept Pharmaceuticals Inc Novartis AG AstraZeneca Plc Bristol-Myers Squibb Co Novo Nordisk AS
Headquarters United States of America Switzerland United Kingdom United States of America Denmark
City Morristown Basel Cambridge Princeton Bagsvaerd
State/Province New Jersey - England New Jersey -
No. of Employees 341 76,057 89,900 34,100 66,015
Entity Type Private Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Vivek Devaraj Chairman; President - U.S. Executive Board - -
Rocco Venezia Chief Financial Officer Senior Management 2023 -
Kathleen Munster Senior Vice President - Technical Operations; Chief Quality Officer Senior Management - -
Meghan Stoll Senior Vice President; Head - U.S. Market Access Senior Management - -
Richard Johnson Senior Vice President; Head - U.S. Human Resources Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Intercept Pharmaceuticals Inc key executives to enhance your sales strategy Gain insight into Intercept Pharmaceuticals Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer